The pharmaceutical industry in India ranks 3rd in the world terms of volume and 14th in terms of value. Hyderabad, Mumbai, Bangalore, and Ahmedabad are the major pharmaceutical hubs of India. India’s cost of production is nearly 33 per cent lower than that of the US. Labour costs are 50–55 per cent cheaper than in Western countries. The cost of setting up a production plant in India is 40 per cent lower than in Western countries. Cost-efficiency continues to create opportunities for Indian companies in emerging markets & Africa. India has a skilled workforce as well as high managerial & technical competence in comparison to its peers in Asia. India has over 546 USFDA – approved company sites, the highest number outside the US. Growing per capita sales of pharmaceuticals in India offers ample opportunities for players in this market. India Pharma 2018- An International Exhibition & Conference on Pharmaceutical Industry will be held in Bangalore International Exhibition Centre, from15th – 17th FEBRUARY, 2018.

Leave a Reply